What is Cromatic?
Founded in 2022, Cromatic operates a sophisticated cloud-based marketplace designed to streamline the R&D outsourcing process for biotech enterprises. The platform serves as a centralized hub where organizations can identify, vet, and manage relationships with best-fit CROs. By integrating specialized task management software, Cromatic enables seamless communication, milestone tracking, and project oversight from initial inception to final delivery. This digital-first approach mitigates the administrative burden typically associated with complex research partnerships, allowing scientific teams to focus on core innovation rather than logistical coordination.
How much funding has Cromatic raised?
Cromatic has raised a total of $5.3M across 1 funding round:
Other Financing Round
$5.3M
Other Financing Round (2023): $5.3M with participation from AgFunder, WorkLife Ventures, FJ Labs, and What If Capital
Key Investors in Cromatic
AgFunder
AgFunder is a global venture capital firm that invests in deeptech platforms, including biotech and AI, to address systemic bottlenecks in health and sustainability.
FJ Labs
FJ Labs is a specialized venture firm focusing on marketplace and network effect businesses, with a proven track record of backing numerous unicorn-status startups.
What If Capital
What If Capital focuses on disruptive healthcare technologies and mental health startups, providing both capital and accelerator support to innovative ventures.
What's next for Cromatic?
With this major enterprise-level funding, Cromatic is well-positioned to accelerate its market penetration and deepen its technological moat. The strategic roadmap likely involves scaling its vendor network and refining its AI-driven matching algorithms to further reduce the time-to-market for critical research projects. As the company continues to capture market share, it will likely focus on enhancing interoperability with existing enterprise resource planning systems used by large-scale pharmaceutical firms. By maintaining its focus on operational efficiency and transparency, Cromatic is poised to become an indispensable utility in the global biotech R&D ecosystem, potentially setting new standards for how research partnerships are managed and executed in a digital-first economy.
See full Cromatic company page
